Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4070292
Max Phase: Preclinical
Molecular Formula: C36H52O20S2
Molecular Weight: 868.93
Molecule Type: Small molecule
Associated Items:
ID: ALA4070292
Max Phase: Preclinical
Molecular Formula: C36H52O20S2
Molecular Weight: 868.93
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](SCc3ccc(CS[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)c4ccccc34)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C36H52O20S2/c37-7-17-21(41)23(43)27(47)33(51-17)55-31-19(9-39)53-35(29(49)25(31)45)57-11-13-5-6-14(16-4-2-1-3-15(13)16)12-58-36-30(50)26(46)32(20(10-40)54-36)56-34-28(48)24(44)22(42)18(8-38)52-34/h1-6,17-50H,7-12H2/t17-,18-,19-,20-,21+,22+,23+,24+,25-,26-,27-,28-,29-,30-,31-,32-,33+,34+,35+,36+/m1/s1
Standard InChI Key: LFRRRAZEVRVKEH-ARQUTJHVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 868.93 | Molecular Weight (Monoisotopic): 868.2493 | AlogP: -5.45 | #Rotatable Bonds: 14 |
Polar Surface Area: 338.60 | Molecular Species: NEUTRAL | HBA: 22 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.87 | CX Basic pKa: | CX LogP: -4.44 | CX LogD: -4.44 |
Aromatic Rings: 2 | Heavy Atoms: 58 | QED Weighted: 0.08 | Np Likeness Score: 0.68 |
1. Kaltner H, Szabó T, Fehér K, André S, Balla S, Manning JC, Szilágyi L, Gabius HJ.. (2017) Bivalent O-glycoside mimetics with S/disulfide/Se substitutions and aromatic core: Synthesis, molecular modeling and inhibitory activity on biomedically relevant lectins in assays of increasing physiological relevance., 25 (12): [PMID:28483453] [10.1016/j.bmc.2017.04.011] |
Source(1):